{
      "brief_title": [
            "darbepoetin",
            "alfa",
            "administer",
            "every",
            "4",
            "week",
            "treatment",
            "subject",
            "anemia",
            "cancer"
      ],
      "brief_summary": [
            "purpose",
            "trial",
            "demonstrate",
            "benefit",
            "respect",
            "hematopoietic",
            "response",
            "subject",
            "anemia",
            "cancer",
            "randomize",
            "darbepoetin",
            "alfa",
            "every",
            "4",
            "week"
      ],
      "condition": [],
      "intervention_type": [
            "Drug"
      ],
      "intervention_name": [
            "Darbepoetin Alfa"
      ],
      "criteria": [
            "eligibility",
            "criterion",
            "subject",
            "malignancy",
            "subject",
            "chemotherapy",
            "anemia",
            "cancer",
            "eastern",
            "cooperative",
            "oncology",
            "group",
            "ecog",
            "status",
            "0",
            "2",
            "hemoglobin",
            "le",
            "equal",
            "adequate",
            "renal",
            "liver",
            "function",
            "write",
            "inform",
            "consent"
      ],
      "gender": "All",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "keyword": [
            "anemia",
            "cancer"
      ],
      "mesh_term": [
            "alfa"
      ],
      "id": "NCT00095277"
}